Genvoya (elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide) is a combination antiretroviral therapy (ART) that treats human immunodeficiency virus (HIV) infections in adults and children. It's made up of two nucleoside reverse transcriptase inhibitors (NRTIs), emtricitabine and tenofovir alafenamide; an integrase strand transfer inhibitor (INSTI) called elvitegravir; and a "booster" medication known as cobicistat. Genvoya is taken by mouth, typically once daily. Some common side effects of this medication include nausea and diarrhea. It's not available as a generic medication.
Genvoya is a combination of four medications:
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
You should take Genvoya as a whole tablet; swallow each tablet whole. Don't crush, split, or chew the tablet since it's known how it'll affect how the medication gets absorbed into the body. Talk to your provider if you're having trouble swallowing pills, especially if it prevents you from taking your HIV medication(s) every day. Your provider can work with you to determine the best treatment option for you.
No, Genvoya isn't FDA-approved for post-exposure prophylaxis (PEP). In PEP, a provider prescribes medications to prevent an HIV infection after someone has been exposed to a person who is infected. If you have questions about PEP, ask your provider about possible options.
No, Genvoya isn't FDA-approved for pre-exposure prophylaxis (prevention), also known as PrEP. A provider prescribes PrEP for a person who is at risk for exposure to HIV, before they've been exposed. If you're interested in taking medications for PrEP, talk to your provider about the best option for you.
People who took Genvoya in clinical studies didn't report weight gain as a side effect. But other studies showed that people who took elvitegravir and tenofovir alafenamide (two of the medications in Genvoya) together had some weight gain in the first 6 months of treatment. Talk to your provider if you're concerned about this side effect.
Genvoya isn't known to cause weight loss as a side effect. But this medication can cause nausea and diarrhea, which can make it difficult for some people to eat or get the proper nutrients through food. It's important to have a conversation with your provider about how to eat a healthy diet before starting treatment. They can also suggest ways to manage side effects like nausea and diarrhea. If you experience unexpected weight loss after starting Genvoya, let your provider know because you might need more medical attention.
Although Genvoya doesn't cause hair loss, some people with HIV infections might lose hair due to other factors. Since HIV is a virus that attacks the body's immune system, it can cause frequent infections, nutritional deficiencies (your body not absorbing enough nutrients), or abnormal hormonal levels. All these changes can cause hair loss.
It can take 2 to 3 days for most of Genvoya to leave your body. This time frame is estimated based on the half-life of elvitegravir, one of the medications in Genvoya. But in order for Genvoya to work well to treat the HIV infection, you must take it very day. If not, the infection can come back and be more difficult to treat. Don't stop taking Genvoya without first speaking to your provider.
Genvoya doesn't contain a protease inhibitor (PI). It's made up of NRTIs (emtricitabine and tenofovir alafenamide), an INSTI (elvitegravir), and a "booster" (cobicistat).
Genvoya can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Before you start Genvoya, your provider will test you for hepatitis B virus (HBV). If you have HBV, suddenly stopping Genvoya might make your liver condition worse (also called an HBV flare-up). Don't stop taking Genvoya without talking with your provider first. Make sure to get your refills on time so that your treatment isn't interrupted. If you need to stop taking Genvoya, your provider might follow up with you for several months after you stop treatment. Your provider will order blood work to check your liver for an HBV flare-up.
Some people taking Genvoya have had kidney problems. Before starting and during treatment with Genvoya, your provider will order blood work or urine tests to check on your kidney health. If you develop kidney problems, you might not experience any noticeable symptoms. But your provider will be able to detect it through labs. Some people developed kidney problems as early as 2 weeks after starting treatment. To prevent kidney injury, it's recommended that you avoid taking other medications that can also harm the kidneys, like high doses of nonsteroidal anti-inflammatory drugs (NSAIDs). Let your provider know right away if you experience bone or muscle pain, pain in your arms or legs, and general weakness that don't go away. These might be signs of kidney problems.
In some rare cases, people who take medications containing NRTIs, such as Genvoya, have reported liver problems, like fatty liver disease. Genvoya can also cause a buildup of lactic acid in the blood (lactic acidosis). Both conditions can be life-threatening.
Make sure to get blood tests done while you take Genvoya so your provider can check for these harmful side effects and make sure the medication is still safe to take. Talk with your provider right away if you experience signs and symptoms of liver damage, such as upper right stomach pain, yellowing of the skin or whites of the eyes, or dark urine. Also, let your provider know if you have symptoms of lactic acidosis, such as feeling weak, muscle pain, and trouble breathing.
Taking Genvoya can cause changes to your immune system called immune reconstitution syndrome. This medical condition happens when your immune system becomes more active after you start Genvoya. Your immune system begins to fight off different infections that it was too weak to fight off before you started treatment. In rare cases, your immune system might improve so much with treatment that it starts to attack normal cells in your body (autoimmune). You can develop immune reconstitution syndrome as early as during the first few weeks of taking Genvoya or many months later. Tell your healthcare provider right away if you start having any new symptoms, such as fever, pain, hair loss, bulging eyes, or sweating, after you start Genvoya.
Taking certain medications for seizures (e.g., carbamazepine (Tegretol)), bacterial infections (e.g., rifampin (Rifadin)), oral steroids (e.g., dexamethasone) or herbal supplements (e.g., St. John's wort) can lower the amount of Genvoya in your body. This can can cause the HIV virus to spread and become harder to treat.
In addition, Genvoya can also raise the amount of other medications in your body when taken together. This raises your risk for side effects from those other medications. For example, taking Genvoya with alfuzosin (Uroxatral) can put you at risk for dangerously low blood pressure. Taking this HIV medication with some blood thinners, like Eliquis (apixaban) or Xarelto (rivaroxaban), can raise your risk for serious bleeds.
Because of the potential for drug interactions with Genvoya, tell your provider and pharmacist about all the medications you take or plan to take. They can make sure your medications are safe to take together.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 150mg/150mg/200mg/10mg | 30 tablets | $4,099.85 | $136.66 |
Each tablet of Genvoya contains 150 mg of elvitegravir, 150 mg of cobicistat, 200 mg of emtricitabine, and 10 mg of tenofovir alafenamide.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Genvoya will not be safe for you to take.